Polymorphism of clotting factors in Hungarian patients with Raynaud's

Amir Houshang Shemirani, Edit Szomják, Emese Balogh, C. András, Dóra Kovács, Judit Ács, Zoltán Csiki

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patients with primary Raynaud's phenomenon may have a genetically determined risk for clotting factors that predispose them to aberrant microvascular thrombosis. We investigated the prevalence of factor V substitution of G to A at position 1691 (FVLeiden), prothrombin G20210A, and methyltetrahydrofolate reductase C677T mutations in these patients. Two hundred (158 women, 42 men, mean age of 42.4 ± 13.7 years) consecutive patients with primary Raynaud's phenomenon and 200 age-sex-matched healthy controls of Hungarian origin were included in a case-control study. The prevalence of methyltetrahydrofolate reductase C677T homozygous among patients was significantly lower than in the control group (odds ratio 0.4, 95% confidence interval 0.2-0.9, P <0.05). The prevalence of other thrombosis-associated alleles did not differ between patients with primary Raynaud's phenomenon and control subjects. FVLeiden, prothrombin G20210A, and polymorphism, prothrombin G20210A mutations have no apparent effect on the etiology of primary Raynaud's phenomenon.

Original languageEnglish
Pages (from-to)56-59
Number of pages4
JournalBlood Coagulation and Fibrinolysis
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Blood Coagulation Factors
Raynaud Disease
Prothrombin
Oxidoreductases
Thrombosis
Mutation
Factor V
Case-Control Studies
Alleles
Odds Ratio
Confidence Intervals
Control Groups

Keywords

  • FVLeiden
  • methyltetrahydrofolate reductase C677T
  • polymorphism
  • prothrombin G20210A
  • Raynaud's phenomenon
  • thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Polymorphism of clotting factors in Hungarian patients with Raynaud's. / Shemirani, Amir Houshang; Szomják, Edit; Balogh, Emese; András, C.; Kovács, Dóra; Ács, Judit; Csiki, Zoltán.

In: Blood Coagulation and Fibrinolysis, Vol. 22, No. 1, 01.2011, p. 56-59.

Research output: Contribution to journalArticle

Shemirani, AH, Szomják, E, Balogh, E, András, C, Kovács, D, Ács, J & Csiki, Z 2011, 'Polymorphism of clotting factors in Hungarian patients with Raynaud's', Blood Coagulation and Fibrinolysis, vol. 22, no. 1, pp. 56-59. https://doi.org/10.1097/MBC.0b013e32834234fe
Shemirani, Amir Houshang ; Szomják, Edit ; Balogh, Emese ; András, C. ; Kovács, Dóra ; Ács, Judit ; Csiki, Zoltán. / Polymorphism of clotting factors in Hungarian patients with Raynaud's. In: Blood Coagulation and Fibrinolysis. 2011 ; Vol. 22, No. 1. pp. 56-59.
@article{d425dcf12f4e43e7a5140a77b40aee4e,
title = "Polymorphism of clotting factors in Hungarian patients with Raynaud's",
abstract = "Patients with primary Raynaud's phenomenon may have a genetically determined risk for clotting factors that predispose them to aberrant microvascular thrombosis. We investigated the prevalence of factor V substitution of G to A at position 1691 (FVLeiden), prothrombin G20210A, and methyltetrahydrofolate reductase C677T mutations in these patients. Two hundred (158 women, 42 men, mean age of 42.4 ± 13.7 years) consecutive patients with primary Raynaud's phenomenon and 200 age-sex-matched healthy controls of Hungarian origin were included in a case-control study. The prevalence of methyltetrahydrofolate reductase C677T homozygous among patients was significantly lower than in the control group (odds ratio 0.4, 95{\%} confidence interval 0.2-0.9, P <0.05). The prevalence of other thrombosis-associated alleles did not differ between patients with primary Raynaud's phenomenon and control subjects. FVLeiden, prothrombin G20210A, and polymorphism, prothrombin G20210A mutations have no apparent effect on the etiology of primary Raynaud's phenomenon.",
keywords = "FVLeiden, methyltetrahydrofolate reductase C677T, polymorphism, prothrombin G20210A, Raynaud's phenomenon, thrombosis",
author = "Shemirani, {Amir Houshang} and Edit Szomj{\'a}k and Emese Balogh and C. Andr{\'a}s and D{\'o}ra Kov{\'a}cs and Judit {\'A}cs and Zolt{\'a}n Csiki",
year = "2011",
month = "1",
doi = "10.1097/MBC.0b013e32834234fe",
language = "English",
volume = "22",
pages = "56--59",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Polymorphism of clotting factors in Hungarian patients with Raynaud's

AU - Shemirani, Amir Houshang

AU - Szomják, Edit

AU - Balogh, Emese

AU - András, C.

AU - Kovács, Dóra

AU - Ács, Judit

AU - Csiki, Zoltán

PY - 2011/1

Y1 - 2011/1

N2 - Patients with primary Raynaud's phenomenon may have a genetically determined risk for clotting factors that predispose them to aberrant microvascular thrombosis. We investigated the prevalence of factor V substitution of G to A at position 1691 (FVLeiden), prothrombin G20210A, and methyltetrahydrofolate reductase C677T mutations in these patients. Two hundred (158 women, 42 men, mean age of 42.4 ± 13.7 years) consecutive patients with primary Raynaud's phenomenon and 200 age-sex-matched healthy controls of Hungarian origin were included in a case-control study. The prevalence of methyltetrahydrofolate reductase C677T homozygous among patients was significantly lower than in the control group (odds ratio 0.4, 95% confidence interval 0.2-0.9, P <0.05). The prevalence of other thrombosis-associated alleles did not differ between patients with primary Raynaud's phenomenon and control subjects. FVLeiden, prothrombin G20210A, and polymorphism, prothrombin G20210A mutations have no apparent effect on the etiology of primary Raynaud's phenomenon.

AB - Patients with primary Raynaud's phenomenon may have a genetically determined risk for clotting factors that predispose them to aberrant microvascular thrombosis. We investigated the prevalence of factor V substitution of G to A at position 1691 (FVLeiden), prothrombin G20210A, and methyltetrahydrofolate reductase C677T mutations in these patients. Two hundred (158 women, 42 men, mean age of 42.4 ± 13.7 years) consecutive patients with primary Raynaud's phenomenon and 200 age-sex-matched healthy controls of Hungarian origin were included in a case-control study. The prevalence of methyltetrahydrofolate reductase C677T homozygous among patients was significantly lower than in the control group (odds ratio 0.4, 95% confidence interval 0.2-0.9, P <0.05). The prevalence of other thrombosis-associated alleles did not differ between patients with primary Raynaud's phenomenon and control subjects. FVLeiden, prothrombin G20210A, and polymorphism, prothrombin G20210A mutations have no apparent effect on the etiology of primary Raynaud's phenomenon.

KW - FVLeiden

KW - methyltetrahydrofolate reductase C677T

KW - polymorphism

KW - prothrombin G20210A

KW - Raynaud's phenomenon

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=78650763589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650763589&partnerID=8YFLogxK

U2 - 10.1097/MBC.0b013e32834234fe

DO - 10.1097/MBC.0b013e32834234fe

M3 - Article

C2 - 21157301

AN - SCOPUS:78650763589

VL - 22

SP - 56

EP - 59

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 1

ER -